machine learning
Boehringer backs AI-powered anti-infective startup ArrePath
Phil Taylor
anti-infectives, antimicrobial resistance, ArrePath, artificial intelligence, digital, digital health, financing, machine learning
0 Comment
Bayer-led project on AI in trials eyes ‘virtual’ placebo groups
Phil Taylor
Aalto University, artificial intelligence, Bayer, clinical trials, Finland, Helsinki University Hospital, machine learning
0 Comment
SMi’s 3rd Annual AI in Drug Discovery Conference
ssapal@smi-online.co.uk
ADMET, ai in drug discovery, artificial intelligence in drug discovery, drug discovery, machine learning
AI in Drug Discovery
Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
CVS Health and Microsoft alliance: an example of an extended partnership
Jessica Hagen
CVS Health, data science, machine learning, Microsoft, Microsoft HealthVault, personalised care
0 Comment
GSK pumps £30m into a new Oxford University partnership
Phil Taylor
Alzheimer's disease, drug discovery, Functional Genomics, GlaxoSmithKline, machine learning, neuroscience, Parkinson's disease, partnering, University of Oxford
0 Comment
R&D/ Video/ Views & Analysis/ Views and analysis
Janssen on driving R&D innovation with data science
mike.hammerton@pharmaphorum.com
AI, Bio-Europe, data science, Janssen, machine learning, Najat Khan, Real World Evidence
0 Comment
AI could be used to guide drug therapy for heart failure
Phil Taylor
artificial intelligence, atrial fibrillation, Birmingham University, digital, digital health, heart failure, machine learning
0 Comment
Real-world study suggest AI may improve atrial fibrillation screening
Phil Taylor
artificial intelligence, atrial fibrillation, Bristol-Myers Squibb, digital, digital health, machine learning, Pfizer
0 Comment